Menveo 58160-0827
Generic: Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine
Product NDC
58160-0827- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- December 9, 2022
- Listing Expires
- December 31, 2027
- Application
- BLA125300
Active Ingredients
| Ingredient | Strength |
|---|---|
| Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen | 10 ug/.5mL |
| Neisseria Meningitidis Group C Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen | 5 ug/.5mL |
| Neisseria Meningitidis Group W-135 Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen | 5 ug/.5mL |
| Neisseria Meningitidis Group Y Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen | 5 ug/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Packaging Options(1)
10 VIAL in 1 CARTON (58160-827-30) / .5 mL in 1 VIAL (58160-827-03)